| 000 | 01022 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517040158.0 | ||
| 264 | 0 | _c20160406 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1750-7448 | ||
| 024 | 7 |
_a10.2217/imt.15.39 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeagu, Martha R | |
| 245 | 0 | 0 |
_aRindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients? _h[electronic resource] |
| 260 |
_bImmunotherapy _c2015 |
||
| 300 |
_a603-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aGlioblastoma _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPortraits as Topic |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aVaccines, Subunit _xtherapeutic use |
| 700 | 1 | _aReardon, David A | |
| 773 | 0 |
_tImmunotherapy _gvol. 7 _gno. 6 _gp. 603-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt.15.39 _zAvailable from publisher's website |
| 999 |
_c25006971 _d25006971 |
||